Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vaccitech plc - American Depositary Shares
(NQ:
VACC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
4.950 (1)
Ask (Size)
5.180 (5)
Prev. Close
5.000
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
38,565,272
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
November 06, 2023
From
Barinthus Biotherapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 31, 2023
Via
Benzinga
Performance
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
October 09, 2023
Via
InvestorPlace
Analyst Expectations for Vaccitech's Future
↗
June 13, 2023
Via
Benzinga
Vaccitech: Q1 Earnings Insights
↗
May 12, 2023
Via
Benzinga
Vaccitech Earnings Perspective: Return On Capital Employed
↗
March 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
↗
September 25, 2023
Via
Benzinga
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise
September 26, 2023
Via
FinancialNewsMedia
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
September 13, 2023
From
Vaccitech plc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
September 11, 2023
Via
Benzinga
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
August 10, 2023
From
Vaccitech plc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
↗
September 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 04, 2023
Via
Benzinga
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
June 21, 2023
From
Vaccitech plc
Via
GlobeNewswire
Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody
June 21, 2023
From
Arbutus Biopharma Corporation
Via
GlobeNewswire
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
June 12, 2023
From
Vaccitech plc
Via
GlobeNewswire
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
↗
June 02, 2023
Via
Benzinga
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
April 17, 2023
From
Vaccitech plc
Via
GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
↗
April 05, 2023
Via
InvestorPlace
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
March 28, 2023
From
Vaccitech plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 24, 2023
Via
Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 24, 2023
Via
Benzinga
Frequently Asked Questions
Is Vaccitech plc - American Depositary Shares publicly traded?
Yes, Vaccitech plc - American Depositary Shares is publicly traded.
What exchange does Vaccitech plc - American Depositary Shares trade on?
Vaccitech plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Vaccitech plc - American Depositary Shares?
The ticker symbol for Vaccitech plc - American Depositary Shares is VACC on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
